featured
Interactions Between Palbociclib and PPIs May Significantly Affect Clinical Outcome in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
ESMO Open 2021 Sep 09;6(5)100231, M Del Re, C Omarini, L Diodati, M Palleschi, I Meattini, S Crucitta, G Lorenzini, C Isca, A Fontana, L Livi, F Piacentini, S Fogli, U De Giorgi, R DanesiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.